Literature DB >> 20026161

Constituents of Corydalis heterocarpa and their anti-proliferative effects on human cancer cells.

You Ah Kim1, Chang-Suk Kong, Sung Su Yea, Youngwan Seo.   

Abstract

Two new coumarins, 1 and 2, along with four known coumarins (3-6) have been isolated from Corydalis heterocarpa. On the basis of spectroscopic and chemical methods, compounds 1 and 2 were elucidated as (2'S,7'S)-O-2-methylbutanoyl-columbianetin and (2'S)-columbianetin-3'-sulfate, respectively. The anti-proliferative activity against human cancer cells of compounds 1-6 isolated from C. heterocarpa was evaluated using a MTT assay and by mRNA expression of several factors related to apoptosis. Among them, compound 2 exerted the more potent anti-proliferative activity compared with the other compounds treated. The potent inhibitory effect of compound 2 was produced by induction of apoptosis through activating Bax, p53 and p21 expressions. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20026161     DOI: 10.1016/j.fct.2009.12.002

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  3 in total

1.  Anti-proliferative activity of Fumaria vaillantii extracts on different cancer cell lines.

Authors:  Fatemeh Haji Abbas Tabrizi; Saeed Irian; Amir Amanzadeh; Fatemeh Heidarnejad; Hoda Gudarzi; Mona Salimi
Journal:  Res Pharm Sci       Date:  2016 Mar-Apr

2.  Crude extract and solvent fractions of Calystegia soldanella induce G1 and S phase arrest of the cell cycle in HepG2 cells.

Authors:  Jung Im Lee; In-Hye Kim; Taek-Jeong Nam
Journal:  Int J Oncol       Date:  2017-01-02       Impact factor: 5.650

3.  Anti-Inflammatory Effect of Columbianetin on Lipopolysaccharide-Stimulated Human Peripheral Blood Mononuclear Cells.

Authors:  Junying Lu; Keyong Fang; Shiji Wang; Lingxin Xiong; Chao Zhang; Zhongmin Liu; Xuewa Guan; Ruipeng Zheng; Guoqiang Wang; Jingtong Zheng; Fang Wang
Journal:  Mediators Inflamm       Date:  2018-04-05       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.